Literature DB >> 17130406

Behavioral features in semantic dementia vs other forms of progressive aphasias.

H J Rosen1, S C Allison, J M Ogar, S Amici, K Rose, N Dronkers, B L Miller, M L Gorno-Tempini.   

Abstract

OBJECTIVE: To compare the behavioral profiles in different variants of primary progressive aphasia (PPA).
METHODS: We classified 67 patients with PPA into three clinical variants: semantic dementia (SEMD), progressive nonfluent aphasia (PNFA), and logopenic progressive aphasia (LPA), and we compared the severity of behavioral dysfunction, as measured by the Neuropsychiatric Inventory, in these groups and patients with frontotemporal dementia (FTD) and Alzheimer disease (AD).
RESULTS: SEMD was associated with significantly more socioemotional behavioral dysfunction than the other two variants of PPA and than AD, specifically more disinhibition, aberrant motor behavior, and eating disorders-behaviors that are typical of FTD. In contrast, PNFA and LPA did not differ from each other or from AD in the type or severity of behavioral dysfunction. Behavioral abnormalities increased in severity with disease duration in SEMD, but this association was not detected in PNFA or LPA.
CONCLUSIONS: Semantic dementia is associated with significantly more behavioral dysfunction than other variants of primary progressive aphasia, specifically behavioral features typical of frontotemporal dementia.

Entities:  

Mesh:

Year:  2006        PMID: 17130406     DOI: 10.1212/01.wnl.0000247630.29222.34

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  69 in total

Review 1.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

2.  Demographic and neuropsychiatric factors associated with off-label medication use in frontotemporal dementia and Alzheimer's disease.

Authors:  Maria Carmela Tartaglia; Bei Hu; Kala Mehta; John Neuhaus; Kristine Yaffe; Bruce L Miller; Adam Boxer
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Apr-Jun       Impact factor: 2.703

3.  Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment.

Authors:  Mandana Modirrousta; Bruce H Price; Bradford C Dickerson
Journal:  Neurodegener Dis Manag       Date:  2013-04-01

Review 4.  Frontotemporal lobar degeneration: current knowledge and future challenges.

Authors:  Chiara Cerami; Elio Scarpini; Stefano F Cappa; Daniela Galimberti
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

Review 5.  An update on primary progressive aphasia.

Authors:  Emily Rogalski; Marsel Mesulam
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

6.  Verbal creativity in semantic variant primary progressive aphasia.

Authors:  Teresa Q Wu; Zachary A Miller; Babu Adhimoolam; Diana D Zackey; Baber K Khan; Robin Ketelle; Katherine P Rankin; Bruce L Miller
Journal:  Neurocase       Date:  2013-12-12       Impact factor: 0.881

Review 7.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

8.  Phenomenology and anatomy of abnormal behaviours in primary progressive aphasia.

Authors:  Jonathan D Rohrer; Jason D Warren
Journal:  J Neurol Sci       Date:  2010-04-18       Impact factor: 3.181

9.  Progranulin-associated primary progressive aphasia: a distinct phenotype?

Authors:  Jonathan D Rohrer; Sebastian J Crutch; Elizabeth K Warrington; Jason D Warren
Journal:  Neuropsychologia       Date:  2010-01       Impact factor: 3.139

10.  Progressive logopenic/phonological aphasia: erosion of the language network.

Authors:  Jonathan D Rohrer; Gerard R Ridgway; Sebastian J Crutch; Julia Hailstone; Johanna C Goll; Matthew J Clarkson; Simon Mead; Jonathan Beck; Cath Mummery; Sebastien Ourselin; Elizabeth K Warrington; Martin N Rossor; Jason D Warren
Journal:  Neuroimage       Date:  2009-08-11       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.